News | Pacemakers | May 09, 2016

Pacemaker Patients With Sleep Apnea at Increased Risk of Atrial Fibrillation

First-ever results show link between pacemaker-detected sleep apnea and atrial fibrillation

May 9, 2016 — Results from a first-of-its-kind study identify a significant increase in the incidence of atrial fibrillation (AF) among patients with pacemaker-detected sleep apnea. The study suggests that monitoring for sleep apnea in patients with pacemakers is imperative in identifying patients’ risk for developing AF. The study was presented at Heart Rhythm 2016, the Heart Rhythm Society’s 37th Annual Scientific Sessions, May 4-7 in San Francisco.

Sleep apnea is a common condition in which breathing stops or becomes critically shallow during sleep. It is associated with cardiovascular diseases and is highly prevalent in patients with pacemakers. While it is understood that sleep apnea is a risk factor for AF, the risk of AF for pacemaker patients with sleep apnea is largely unknown.

The study enrolled a total of 150 patients with atrio-ventricular block or sick sinus syndrome who underwent implantation of a dual-chamber pacemaker. The patients were monitored for sleep apnea events during the first week after the device was implanted. The severity of sleep apnea in patients was determined by the pacemakers’ ApneaScan algorithm (Boston Scientific), which automatically detects sleep apnea events. Sleep apnea was defined as severe if a patient had 30 or more events per hour for at least one night. If the device detected arrhythmias for more than one hour in a day, patients were considered to have experienced AF episodes.

During an eight-month follow-up, AF occurred in 36 percent of patients and, specifically, in 25 (28 percent) out of the 89 patients who had no history of the arrhythmia. Severe sleep apnea was detected in 85 patients, 56 of whom had no history of AF. In presence of severe sleep apnea, the risk of AF was three-fold higher in the overall population, and approximately six-fold higher among those with no previous history of AF.

“In recent years, pacemakers have increasingly become equipped with sleep apnea monitoring measures, and in using these tools, we were able to identify how pacemaker patients with sleep apnea are at risk for developing atrial fibrillation,” said Andrea Mazza, M.D., Santa Maria della Stella Hospital. “Our results are the first to show that patients with pacemakers and sleep apnea are at a higher risk of developing atrial fibrillation. Now that we understand the connection, it’s important that patients and doctors, collectively, are more diligent about monitoring for sleep apnea in order to engage in solutions that may prevent the development of atrial fibrillation and, possibly, thromboembolic complications.”

Study authors note that a high prevalence of sleep apnea in patients with pacemakers requires a more defined approach to diagnosis in order to explore potential therapeutic targets for reducing occurrence and recurrence of AF.

For more information: www.hrsonline.org

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init